On the evening of June 29, BOE A and IBM signed the Software License and Joint Development Agreement. Under the agreement, the company conducts joint development work by obtaining licenses from IBM related software, copyrights, know-how and materials. The two sides will establish a joint team to jointly develop a health management big data platform based on cognitive computing. The development period is five years. In the first year, the two parties will mainly develop a health management platform based on cognitive computing; an expert knowledge base system based on cardiovascular and cerebrovascular health; and a mobile health management system based on cardiovascular and cerebrovascular health. The joint development in the next four years will be based on the negotiation of the needs of both parties. The company said that it will develop a health management and results-oriented analysis system based on the acquisition of specific licensed software and related materials. By partnering with IBM to develop a cognitive computing-based health management platform, the company will strengthen its research and development capabilities for big data and artificial intelligence to drive the rapid development of the company's health care business strategy and enhance the company's competitiveness in the health care sector. According to the previous announcement, BOE A plans to invest nearly 3 billion yuan to enter the smart medical industry. The company plans to acquire all the shares of Mingde Investment for RMB 250 million to establish a health care investment and development platform. The core operating entity of Mingde Investment is Beijing Mingde Hospital Co., Ltd. At the same time, the company plans to use Mingde Investment as the investment development platform for the company's health care business, and renamed it as BOE Healthcare Investment Management Co., Ltd., increasing the registered capital from 148 million to 3 billion yuan. In addition, the company signed a Memorandum of Understanding with Dignity, a leading health care company in the United States. The company and Dignity are willing to seek opportunities to collaborate in China, and Dignity can support the company's operating hospitals and new hospital projects. Vegetable Powder,Strawberry Powder,Watermelon Powder,Organic Wolfberry Powder Xi'an XJeson Biotech Co., Ltd , https://www.xjesonbio.com